Injection site rotation: a plan for daily, weekly and twice-daily shots

Reviewed 12 sourcesPublished by PepVault

How to rotate injection sites: a zone plan for weekly GLP-1, daily and twice-daily shots, how long a spot rests, and how to check a site for lumps by touch.

Older hands in burgundy sleeves hold a crimp-sealed vial upright between the palms, oranges behind
Last reviewed
Sources
12
Questions
9
Compounds
5

The short answer

Split your sites into zones: four belly quarters, 5 cm (2 inches) clear of the navel, plus each thigh. Use one zone at a time, always in the same order. A weekly shot takes the next zone each week; a daily shot stays in one zone for a week, each spot about 2.5 cm (an inch) from the last. Before each new zone, feel it and skip anything firm.

Every number checked at its primary source · · 12 sources · How we research

Evidence: FDA labels (as of November 2026) for the rotation instructions; insulin-injection expert recommendations, an evidence summary, a meta-analysis and human observational and education studies for the plan, the check and lumps. No study measures rotation or lipohypertrophy with peptides themselves.

Older hands in burgundy sleeves hold a crimp-sealed vial upright between the palms, oranges behind

What does a rotation plan look like?

A rotation plan has two levels. The first is the zone: a patch of skin you use for a while before moving on. The second is the spot: the exact point inside that zone where today's needle goes. Expert injection guidance, written for insulin (the most studied under-the-skin shot), splits the belly into four quarters and each thigh, buttock and upper arm into two halves. You use one quarter or half for a week, then move to the next one clockwise or anticlockwise, and every new spot sits at least 1 to 2 cm from the one before67.

The belly split into four numbered quarters around a 5 cm circle at the navel, with a week of seven injection spots in an arc in quarter 1, each 2.5 cm apart
Four belly quarters, used one at a time in a fixed order. In a daily week the seven dots sit in one quarter, each a finger-width or more from the last.

A fixed order means you only ever need to remember the last spot. Where the zones are on the body, and why the shot goes into fat, is in our guide to where to inject peptides; this page is about the order.

PepVault logs the site with every dose, pre-selects the site in your rotation you used longest ago, and shows how many days each site has rested. Log it in PepVault

Injection GuideSee each site on a body in 3DThe belly, the thigh and the back of the arm on a body you can turn, with the skin opened up to scale to show where the needle tip sits in the fat. Steps for a vial and syringe, a multi-dose pen or a single-dose pen.Open the Injection Guide
A smiling woman in a blue top leaning on her kitchen counter with her phone and a notebook

PepVault for iPhone

Keep your protocol in PepVault

PepVault logs the site with every dose, pre-selects the site in your rotation you used longest ago, and shows how many days each site has rested.

Download on the App Store

7 days free on the yearly plan for new subscribers.

How long before you come back to the same spot?

No study sets a minimum number of days. What the guidance fixes is the pattern: a new spot every time, one zone at a time, and a full lap of the zones before you return67. How long a spot rests then follows from how often you inject. As of November 2026, the labels below set the schedules, and each one says to rotate12345. The zone counts are the plan on this page.

Schedule (label example)Shots a yearZones in the lapA zone comes back every
Weekly: semaglutide (Wegovy), tirzepatide (Zepbound)526: four belly quarters, two thighs6 weeks
Daily: liraglutide (Saxenda)3656: one zone per week6 weeks, with 7 spots used per visit
Daily, belly only: tesamorelin (Egrifta WR)3654 belly quarters4 weeks
Twice daily: exenatide (Byetta)7304 belly quarters for mornings, 4 thigh halves for evenings4 weeks for each

A weekly injector has far more room than a daily one: 52 shots a year against 365. In a meta-analysis of 51 insulin studies (two of its authors work for the needle maker embecta), more than two injections a day raised the odds of lipohypertrophy, the rubbery thickening of fat that repeated injections cause, by 2.27 times9. The more often you inject, the more a written plan earns its place.

How do you rotate a weekly GLP-1 shot?

The tirzepatide label puts it as: change (rotate) your injection site with each weekly injection; you may stay in the same area, at a different spot in it1. The semaglutide label says the same for each injection2. One simple way to do it:

  1. Number six zones: right upper belly, right lower belly, left lower belly, left upper belly, left thigh, right thigh. Keep the belly zones 5 cm (2 inches) from the navel.
  2. On shot day, use the zone after last week's. Week 7 starts again at zone 1.
  3. Inside the zone, pick a spot at least 2.5 cm (an inch) from where you went last time in that zone.
  4. Feel the zone with your fingertips before you inject (the check is below). Skip any patch that is firm, lumpy, bruised or sore.
  5. Write down the zone, or log it, the moment you are done: a week is long enough to forget which side you used.
A front body outline with six numbered zones, four belly quarters and both thighs, and a strip pairing weeks 1 to 7 with zones 1 to 6 and back to zone 1
Six zones, one a week: each zone gets a six-week rest before its turn comes again.

If someone else can give the shot, the backs of both upper arms add two more zones and stretch the lap to eight weeks. The tirzepatide label says the arm should be injected by another person1.

How do you rotate a daily shot?

A daily injector uses up a zone in a week, so the zone becomes the week and the spot becomes the day. The liraglutide label adds a reason of its own: rotate within the same region to lower the risk of cutaneous amyloidosis, a firm lump made of protein deposits under the skin3.

  1. Give each week one zone, in a fixed order: belly quarters first, then each thigh.
  2. Inside the week's zone, lay the seven days out in a row or a small arc, each spot about 2 cm (just under an inch) from the day before: the guidance asks for at least 1 to 2 cm, and seven spots then fit inside one belly quarter67.
  3. Day 8 moves to the next zone. With six zones, a zone comes back after six weeks.
  4. When the lap brings you back to a zone, shift the row half a spot over, so the new spots fall between last time's.

Some labels keep you on the belly. Tesamorelin's says to rotate injection sites to different areas of the abdomen and to skip scar tissue, bruises and the navel5. Its plan is the four quarters alone, one a week, each coming back every four weeks.

What changes with two shots a day?

Twice a day doubles the spots, so split the two doses between areas. The Indian injection-technique recommendations (FITTER India) use a rule called same time, same site: the dose at a given time of day always goes in the same area, and an international evidence summary adds that doses at different times go in different areas67. Exenatide's twice-daily pen label asks you to rotate within the area you chose with each dose4.

  • Mornings: the four belly quarters, one per week.
  • Evenings: the thighs, split into four halves (upper and lower on each side), one per week.
  • Each dose: a new spot about 2 cm (just under an inch) from the last one in that zone.

For insulin the rule exists because the belly absorbs faster than the thigh6. Semaglutide and tirzepatide reach similar levels from the belly, thigh and upper arm12, so for them the rule just makes the plan easy to keep.

How do you check a site for lipohypertrophy with your fingers?

Lipohypertrophy is often easier to feel than to see: large patches show, while others turn up only under the fingers6. In a study of 40 insulin users with lesions confirmed on ultrasound, health workers trained in a set routine of looking and touching found 96% of the lesions, against 72% for untrained ones. Small, flat patches on the arm were the ones most often missed10. The routine below follows that study and a 2026 evidence summary710.

  1. Stand in good light, natural if you can, with the zone bare. Look at the skin from the side as you turn, so a raised patch casts a shadow.
  2. Relax the muscles underneath: for the belly, lie back.
  3. Glide your fingertips over the zone in slow circles, then up and down, then side to side, starting light.
  4. Go over it again with firmer pressure: deeper patches only show up then.
  5. Feel for skin that is firmer, rubbery or thicker than the skin around it.
  6. Pinch the patch between your thumb and index finger, then pinch skin you never inject. A patch whose fold is thicker is one to skip.
  7. Mark its edges with a skin-safe pen or take a photo, so you can see whether it shrinks.

Lesions in that study averaged 4.8 cm across, about the size of a golf ball, and more than half (22 of 40) were flat rather than raised10.

What do you do when you find a lump?

Stop injecting there. The guidance is plain: no injections into lipohypertrophy, inflamed, swollen or infected skin68. The tirzepatide label says not to inject where the skin has pits, is thickened or has lumps1. Take the zone out of the lap and let the rest of the plan carry on.

Patches shrink slowly once they are left alone, at a pace that differs from person to person7. Ultrasound sorts insulin lipohypertrophy into three kinds; in one study of 255 people with it, 65% were nodular, 28% diffuse and 7% a darker type on the scan. Follow-up studies found the nodular kind could resolve completely within six months, while the other two took longer711. A simple habit (ours, not a guideline rule): feel the patch once a month and bring the zone back when it feels like the skin around it.

If you also inject insulin, the same dose can act more strongly in healthy skin than in a lump, so that switch is one to plan with your physician6.

Skipping a zone is one tap on a different site in PepVault's body map, and the log keeps every site with its date, so you can see how long a patch has rested. Log it in PepVault

When to get help A lump that is red, warm, painful or growing, or that comes with a fever, is a reason to contact your clinician, as is a firm lump that does not shrink once you stop injecting there.

Do needle reuse and the device change the plan?

Needle reuse adds to the risk, and rotation counts for more. Across the 51 insulin studies in the meta-analysis, incorrect rotation raised the odds 8.85 times and needle reuse 3.20 times; whether people used pens or syringes made no significant difference9.

  • Multi-dose pens (Wegovy, Saxenda): always a new needle for each injection23.
  • Single-dose pens: the needle is built in, and the whole pen goes into a sharps container after one use1.
  • Vials and syringes: the tirzepatide vial instructions say a new syringe and needle every time1.
  • Sharing: never share a pen between people, even with a new needle12.

Teaching helps. In a Belgian study of 146 people who inject insulin, six months of single-use 4 mm needles and online lessons on rotation cut incorrect rotation from 37.0% to 4.1%, and injecting into lumpy zones from 51.4% to 7.5%12.

What do people who rotate report?

Commonly reported: weekly injectors most often forget which side they used last week, and a note or log fixes it; daily injectors run short of belly room and add the thighs; people mark the last spot with a pen dot or a phone photo; and a small bruise or pink patch now and then is the most common thing they find on a check.

These are user reports, not trial results. How often lipohypertrophy happens with peptides has not been measured: the numbers on this page come from insulin, which itself makes fat grow, and the GLP-1 labels still ask for rotation with every dose123.

Track it in the app

Sources

  1. Eli Lilly and Company. ZEPBOUND (tirzepatide) injection: prescribing information, patient information and instructions for use. DailyMed, version effective 2026-08-28. dailymed.nlm.nih.gov
  2. Novo Nordisk. WEGOVY (semaglutide) injection: prescribing information, medication guide and instructions for use. DailyMed, version effective 2026-06-18. dailymed.nlm.nih.gov
  3. Novo Nordisk. SAXENDA (liraglutide) injection: prescribing information and instructions for use. DailyMed, revised 06/2026. dailymed.nlm.nih.gov
  4. AstraZeneca. BYETTA (exenatide) injection: prescribing information and pen user manual. DailyMed, version effective 2025-09-02. dailymed.nlm.nih.gov
  5. Theratechnologies. EGRIFTA WR (tesamorelin) for injection: prescribing information and patient information. DailyMed, version effective 2026-07-29. dailymed.nlm.nih.gov
  6. Tandon N, Kalra S, Balhara YPS et al. Forum for Injection Technique and Therapy Expert Recommendations, India: the Indian recommendations for best practice in insulin injection technique, 2017. Indian J Endocrinol Metab. 2017. PubMed 28670547
  7. Xie T, Cao C, Li Z et al. Best evidence summary for managing insulin injection-related lipohypertrophy: an international and contextualized synthesis. J Multidiscip Healthc. 2026. PubMed 43048676
  8. Frid AH, Kreugel G, Grassi G et al. New insulin delivery recommendations (FITTER). Mayo Clin Proc. 2016. PubMed 27594187
  9. Mader JK, Fornengo R, Hassoun A et al. Risk factors for lipohypertrophy in people with insulin-treated diabetes: a systematic meta-analysis. J Diabetes Sci Technol. 2025. PubMed 40109173
  10. Gentile S, Guarino G, Giancaterini A, Guida P, Strollo F. A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes. SpringerPlus. 2016. PubMed 27213130
  11. Yang H, Zhang L, Dong Q et al. The distinct ultrasound characteristics and prognostic features of insulin-induced lipohypertrophy: a systematic review. Diabetes Metab Syndr Obes. 2025. PubMed 40176968
  12. Bochanen N, Decochez K, Heleu E et al. Lipohypertrophy Monitoring Study (LIMO): effect of single use of 4 mm pen needles combined with education on injection site rotation on glycaemic control. Diabet Med. 2022. PubMed 34407260

Newsletter · Weekly

The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

We’ll email you a link to confirm. Your address is used for the briefing only. Privacy

PepVault for iPhone

Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo